CHARLES SANG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES SANG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES SANG. CHARLES SANG is SVP, Clinical Diagnostics in Adaptive Biotechnologies Corp ($ADPT) and SVP, External Affairs in Adaptive Biotechnologies Corp ($ADPT).
Latest Insider Trading Transactions of CHARLES SANG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Option Exercise | M | 6.55 | 50,000 | 327,500 | 155,000 | |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Sell | S | 56.13 | 50,000 | 2,806,500 | 0 | 50 K to 0 (-100.00 %) |
| Dec 11 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Buy | M | 6.55 | 50,000 | 327,500 | 50,000 | 0 to 50 K |
| Sep 16 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Option Exercise | M | 6.32 | 25,000 | 158,000 | 55,000 | |
| Sep 16 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Option Exercise | M | 6.55 | 25,000 | 163,750 | 205,000 | |
| Sep 16 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Sell | S | 44.00 | 25,000 | 1,100,000 | 0 | 25 K to 0 (-100.00 %) |
| Sep 16 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Buy | M | 6.32 | 25,000 | 158,000 | 25,000 | 0 to 25 K |
| Sep 16 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Sell | S | 42.50 | 25,000 | 1,062,500 | 0 | 25 K to 0 (-100.00 %) |
| Sep 16 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, External Affai ... | Buy | M | 6.55 | 25,000 | 163,750 | 25,000 | 0 to 25 K |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Option Exercise | M | 6.55 | 20,000 | 131,000 | 230,000 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Option Exercise | M | 6.55 | 20,000 | 131,000 | 230,000 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Option Exercise | M | 6.32 | 20,000 | 126,400 | 80,000 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Option Exercise | M | 6.32 | 20,000 | 126,400 | 80,000 | |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Sell | S | 38.01 | 40,000 | 1,520,400 | 0 | 40 K to 0 (-100.00 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Sell | S | 38.01 | 40,000 | 1,520,400 | 0 | 40 K to 0 (-100.00 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Buy | M | 6.55 | 20,000 | 131,000 | 40,000 | 20 K to 40 K (+100.00 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Buy | M | 6.55 | 20,000 | 131,000 | 40,000 | 20 K to 40 K (+100.00 %) |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Buy | M | 6.32 | 20,000 | 126,400 | 20,000 | 0 to 20 K |
| May 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Buy | M | 6.32 | 20,000 | 126,400 | 20,000 | 0 to 20 K |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | SANG CHARLES | SVP, Clinical Diagn ... | Option Exercise | A | 31.71 | 40,000 | 1,268,400 | 40,000 |
Page: 1